DB X-Trackers Harvest Csi 300 C (ASHR) 34.52

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
DB X-Trackers Harvest Csi 300 C (ASHR) 34.52 $ASHR

Correction Seems Over: Time for China ETFs?
Zacks Equity Research - Zacks Investment Research - Wed Sep 09, 10:27AM CDT
After a heavy sell-off, are China ETFs trading at fair value now?
PEK: 43.27 (+1.01), CNXT: 36.83 (+0.94), KBA: 44.23 (+1.10), ASHR: 34.52 (+0.93), FXI: 38.66 (+1.55), ASHS: 38.84 (+0.74)

On Chinese Stimulus Hopes, 3 ETFs Surging over 10%
Maher Syed - Zacks Investment Research - Tue Sep 08, 4:01PM CDT
China’s foreign trade dropped by 9.7% in August, with exports falling 6.1% and imports taking a 13.8% dive.
KBA: 44.23 (+1.10), ASHR: 34.52 (+0.93), ASHS: 38.84 (+0.74)

Chinese Shares Rise 2.9%, Erase Monday's Losses
at The Street - Tue Sep 08, 5:05AM CDT
Chinese share prices that crashed in June barely change Tuesday, but an ominous drum roll is sounding in the distance.
IVZ: 33.00 (+0.50), ASHR: 34.52 (+0.93), FXI: 38.66 (+1.55)

Why You Should Buy China Soon - Video Blog
Kevin Cook - Zacks Investment Research - Thu Jul 30, 3:33PM CDT
The transition to a consumer-driven economy will create fortunes over the next decade.
SBUX: 58.78 (+0.09), SPY: 199.41 (+1.62), AAPL: 110.78 (-0.53), ASHR: 34.52 (+0.93)

China Stock Strategy -- Here's How to Profit From the Selloff
at The Street - Tue Jul 28, 9:00AM CDT
Instead of being worried, investors can take advantage of the selloff with exchange traded funds that bet against the Chinese market, also known as bear funds.
YANG: 86.02 (-12.01), YXI: 27.73 (-1.01), ASHR: 34.52 (+0.93), FXI: 38.66 (+1.55), CHAD: 47.30 (-1.12)

China Stocks Suffer Sharpest Plunge Since 2007
at Investor's Business Daily - Mon Jul 27, 12:13PM CDT
The efforts of China's government to tame its unruly stock markets hit a big speed bump Monday, as Chinese shares suffered their sharpest plunge in eight years. Concerns about China's slowing economic growth as well as doubts about the effectiveness...
AFTY: 15.96 (+0.49), CAF: 24.79 (+0.53), UTX: 93.51 (+0.96), DANG: 6.56 (+0.19), GM: 33.05 (+0.83), CMCM: 17.70 (+0.89), CAT: 70.38 (-0.44), ASHR: 34.52 (+0.93), BITA: 32.98 (+0.11), JKS: 25.88 (+0.74), BABA: 66.28 (+2.36)

Shanghai Stock Turbulence Will Slow Ticker Trend
at The Street - Thu Jul 16, 3:54PM CDT
Chinese companies listed on U.S. exchanges are rethinking plans to move their tickers back to mainland China, amid the turbulence in the Shanghai stock market.
ASHR: 34.52 (+0.93), FXI: 38.66 (+1.55)

How China's 'Casino Mentality' Fueled the Stock Market Frenzy
at The Street - Wed Jul 15, 4:59AM CDT
Mom and pop investors, often members of the vast new middle class, were eager not to miss out on a seemingly endless market rally. Then came the plunge.
CAF: 24.79 (+0.53), ASHR: 34.52 (+0.93)

Zacks Investment Ideas feature highlights: The Best, Most Interesting ETFs to Launch in the First Half 2015 - Press Releases
Zacks Equity Research - Zacks Investment Research - Tue Jul 14, 8:30AM CDT
Zacks Investment Ideas feature highlights: The Best, Most Interesting ETFs to Launch in the First Half 2015
XOP: 39.10 (+0.17), XT: 24.08 (+0.23), UBIO: 9.19 (+0.55), XBI: 64.30 (+1.08), IBB: 307.79 (+5.88), LABU: 17.74 (+0.89), ZBIO: 30.47 (-1.94), CHAD: 47.30 (-1.12), YLCO: 11.10 (+0.08), LABD: 50.05 (-2.69), DRIP: 51.85 (-0.40), ASHR: 34.52 (+0.93), GUSH: 16.26 (+0.18)

4 China A-Shares ETFs Pick Up After Gloom - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Jul 10, 11:24AM CDT
4 top-ranked China ETFs are worth a look on fair valuation after the market bounced back following a heavy sell-off.
CNXT: 36.83 (+0.94), ASHR: 34.52 (+0.93)

Investors React to China Stock Crash: A Look at 3 Volatile Chinese ETFs - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Wed Jul 08, 6:09PM CDT
China stocks are crashing but it has actually been good news for a few ETFs tracking the country.
YANG: 86.02 (-12.01), YINN: 22.61 (+2.46), ASHR: 34.52 (+0.93), CHAD: 47.30 (-1.12)

Chinese shares doubt Beijing's support measures
Seeking Alpha - at Seeking Alpha - Tue Jul 07, 1:29AM CDT

EWH: 20.05 (+0.28), JFC: 15.34 (+0.44), PEK: 43.27 (+1.01), CNXT: 36.83 (+0.94), CAF: 24.79 (+0.53), KBA: 44.23 (+1.10), CQQQ: 31.87 (+0.63), CHXF: 55.14 (+1.64), YINN: 22.61 (+2.46), FXP: 37.91 (-3.39), EWHS: 23.46 (-0.19), PGJ: 27.75 (+0.37), FCA: 21.45 (+0.75), CHN: 17.11 (+0.51), YAO: 25.75 (+0.74), FCHI: 47.91 (+0.62), ASHR: 34.52 (+0.93), CHAU: 20.42 (+0.99), GXC: 74.73 (+2.32), FXI: 38.66 (+1.55), ASHS: 38.84 (+0.74), XPP: 55.99 (+4.24), KWEB: 32.78 (+0.63), ECNS: 44.10 (+0.89), TAO: 20.33 (+0.40), CHNA: 34.17 (-0.53), QQQC: 20.47 (+0.35), CHIX: 14.69 (+0.51), KFYP: 56.23 (unch), HAO: 25.31 (+0.83), MCHI: 47.51 (+1.67), CHIM: 13.45 (+0.24), YANG: 86.02 (-12.01), AFTY: 15.96 (+0.49), CHIQ: 13.13 (+0.33), GCH: 9.08 (+0.18), CHIE: 12.08 (+1.43), TDF: 19.72 (+0.65), FHK: 34.19 (+0.40), CHII: 14.94 (+0.53), YXI: 27.73 (-1.01), CN: 33.68 (+0.70)

One Photo That Will Convince You To Sell China
ColoradoWealthManagementFund - at Seeking Alpha - Mon Jul 06, 2:11PM CDT

EWH: 20.05 (+0.28), HAO: 25.31 (+0.83), MCHI: 47.51 (+1.67), ASHR: 34.52 (+0.93), GXC: 74.73 (+2.32), FXI: 38.66 (+1.55)

Asia closes down after Greek vote; China bounces back
Seeking Alpha - at Seeking Alpha - Mon Jul 06, 2:22AM CDT

EWH: 20.05 (+0.28), JFC: 15.34 (+0.44), PEK: 43.27 (+1.01), CNXT: 36.83 (+0.94), CAF: 24.79 (+0.53), KBA: 44.23 (+1.10), CQQQ: 31.87 (+0.63), CHXF: 55.14 (+1.64), YINN: 22.61 (+2.46), FXP: 37.91 (-3.39), EWHS: 23.46 (-0.19), PGJ: 27.75 (+0.37), FCA: 21.45 (+0.75), CHN: 17.11 (+0.51), YAO: 25.75 (+0.74), FCHI: 47.91 (+0.62), ASHR: 34.52 (+0.93), CHAU: 20.42 (+0.99), GXC: 74.73 (+2.32), FXI: 38.66 (+1.55), ASHS: 38.84 (+0.74), XPP: 55.99 (+4.24), KWEB: 32.78 (+0.63), ECNS: 44.10 (+0.89), TAO: 20.33 (+0.40), CHNA: 34.17 (-0.53), QQQC: 20.47 (+0.35), CHIX: 14.69 (+0.51), KFYP: 56.23 (unch), HAO: 25.31 (+0.83), MCHI: 47.51 (+1.67), CHIM: 13.45 (+0.24), YANG: 86.02 (-12.01), AFTY: 15.96 (+0.49), CHIQ: 13.13 (+0.33), GCH: 9.08 (+0.18), CHIE: 12.08 (+1.43), TDF: 19.72 (+0.65), FHK: 34.19 (+0.40), CHII: 14.94 (+0.53), YXI: 27.73 (-1.01), CN: 33.68 (+0.70)

Asia tumbles following Greek referendum; China gives up massive early gain
Seeking Alpha - at Seeking Alpha - Mon Jul 06, 12:41AM CDT

EWH: 20.05 (+0.28), JFC: 15.34 (+0.44), PEK: 43.27 (+1.01), CAF: 24.79 (+0.53), KBA: 44.23 (+1.10), YINN: 22.61 (+2.46), CHXF: 55.14 (+1.64), EWJ: 12.03 (+0.19), DXJ: 51.56 (+0.91), FXP: 37.91 (-3.39), PGJ: 27.75 (+0.37), CHN: 17.11 (+0.51), FCA: 21.45 (+0.75), YAO: 25.75 (+0.74), ASHR: 34.52 (+0.93), CHAU: 20.42 (+0.99), GXC: 74.73 (+2.32), FXI: 38.66 (+1.55), XPP: 55.99 (+4.24), CHNA: 34.17 (-0.53), MCHI: 47.51 (+1.67), YANG: 86.02 (-12.01), AFTY: 15.96 (+0.49), GCH: 9.08 (+0.18), TDF: 19.72 (+0.65), YXI: 27.73 (-1.01), CN: 33.68 (+0.70)

China scrambles to end stock market rout
Seeking Alpha - at Seeking Alpha - Sun Jul 05, 10:17AM CDT

EWH: 20.05 (+0.28), JFC: 15.34 (+0.44), PEK: 43.27 (+1.01), CNXT: 36.83 (+0.94), CAF: 24.79 (+0.53), KBA: 44.23 (+1.10), CQQQ: 31.87 (+0.63), CHXF: 55.14 (+1.64), YINN: 22.61 (+2.46), FXP: 37.91 (-3.39), EWHS: 23.46 (-0.19), PGJ: 27.75 (+0.37), FCA: 21.45 (+0.75), CHN: 17.11 (+0.51), YAO: 25.75 (+0.74), FCHI: 47.91 (+0.62), ASHR: 34.52 (+0.93), CHAU: 20.42 (+0.99), GXC: 74.73 (+2.32), FXI: 38.66 (+1.55), ASHS: 38.84 (+0.74), XPP: 55.99 (+4.24), KWEB: 32.78 (+0.63), ECNS: 44.10 (+0.89), TAO: 20.33 (+0.40), CHNA: 34.17 (-0.53), QQQC: 20.47 (+0.35), CHIX: 14.69 (+0.51), KFYP: 56.23 (unch), HAO: 25.31 (+0.83), MCHI: 47.51 (+1.67), CHIM: 13.45 (+0.24), YANG: 86.02 (-12.01), AFTY: 15.96 (+0.49), CHIQ: 13.13 (+0.33), GCH: 9.08 (+0.18), CHIE: 12.08 (+1.43), TDF: 19.72 (+0.65), FHK: 34.19 (+0.40), CHII: 14.94 (+0.53), YXI: 27.73 (-1.01), CN: 33.68 (+0.70)

China's Stock Bubble Complication
Joseph Calhoun - at Seeking Alpha - Fri Jul 03, 7:24AM CDT
By Jeffrey P. Snider The Shanghai Composite Index for shares on China's somewhat stock market peaked on June 12, a Friday before a weekend in which every major analyst and China-watcher expected the PBOC to unleash rate cuts . It wasn't a very...
XPP: 55.99 (+4.24), JFC: 15.34 (+0.44), PEK: 43.27 (+1.01), CAF: 24.79 (+0.53), KBA: 44.23 (+1.10), CHNA: 34.17 (-0.53), CHXF: 55.14 (+1.64), YINN: 22.61 (+2.46), MCHI: 47.51 (+1.67), YANG: 86.02 (-12.01), AFTY: 15.96 (+0.49), FXP: 37.91 (-3.39), GCH: 9.08 (+0.18), PGJ: 27.75 (+0.37), FCA: 21.45 (+0.75), CHN: 17.11 (+0.51), TDF: 19.72 (+0.65), YAO: 25.75 (+0.74), YXI: 27.73 (-1.01), CN: 33.68 (+0.70), ASHR: 34.52 (+0.93), CHAU: 20.42 (+0.99), FXI: 38.66 (+1.55), GXC: 74.73 (+2.32)

Margin Debt In Shanghai Falls For 9th Day In A Row
China Stock Research - at Seeking Alpha - Fri Jul 03, 3:45AM CDT
Data provided by the Shanghai stock exchange showed that margin debt has fallen for nine straight days, down to 1.3 trillion RMB as of July 2, compared to nearly 1.5 trillion RMB on June 18. When including July 1 end-of-day data from Shenzhen, the...
PEK: 43.27 (+1.01), AFTY: 15.96 (+0.49), CNXT: 36.83 (+0.94), CAF: 24.79 (+0.53), KBA: 44.23 (+1.10), CHNA: 34.17 (-0.53), ASHR: 34.52 (+0.93), CHAU: 20.42 (+0.99), ASHS: 38.84 (+0.74)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading